Biopharmaceutical bioseparation is a process of purifying or separating a biological product or biopharmaceutical of interest such as a monoclonal antibody, protein, and cells on a large scale from a complex mixture of biomolecules. These purified biopharmaceuticals are then used for their chemical properties such as neurological activity, antibacterial activity, and metabolic activity. The life sciences sector comprises pharmaceutical, biotech, and health care segments. It is generating significant revenue globally. This has been partly attributed to emerging markets and positive demographics in those markets as well as due to global leading edge research resulting in blockbuster innovations. These innovations are facilitated by rigorous R&D efforts by global players and academia in all the segments mentioned above. The world of medicine has seen a new wave of therapies which are specific and targeted to a particular patient. Demand for more targeted biological solutions is likely to increase significantly, as drugs and therapies evolve to meet demand for a more targeted approach. Six of the top 10 selling drugs globally in 2015 were biologics. This rise in demand is estimated to propel the global biopharmaceutical bioseparation systems market during the forecast period. Purification of these biopharmaceuticals through bioseparation involves a long sequence of complex and sensitive steps comprising filtration, extraction, chromatography, drying, and analysis.
The global biopharmaceutical bioseparation systems market can be segmented based on technique and region. In terms of technique, the biopharmaceutical bioseparation systems market can be divided into chromatography technique, membrane-based bioseparation, centrifugation technology, cell disruption technology, precipitation, extraction technique, and filtration technologies. Based on region, the global biopharmaceutical bioseparation systems market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is projected to be the most lucrative market for biopharmaceutical bioseparation systems during the forecast period due to high production capabilities and high per capita health care expenditure. Launch of new, innovative products and an expanding skill base in North America implies that more people in the region will have access to powerful technology during the forecast period. The biopharmaceutical bioseparation systems market in the region is well-developed as compared to others. Hence, replacement of products is expected to drive the biopharmaceutical bioseparation systems market during the forecast period. Additionally, evolving research and development in dynamic fields such as genomics, pharmaceutical sciences, and biotechnology would necessitate higher investments by end-users for equipment to cater to the rising research and analysis needs. Moreover, consumer preference for automation will lead to increase in demand for automated bioseparation systems that handle multiple samples with high degree of accuracy rendered by automation. The U.S. and Europe are the most attractive markets for biopharmaceutical bioseparation systems. This is attributed to these regions being in the forefront of medicinal export and import, with many key biopharmaceutical companies located in these regions. High adoption of novel treatment options and rapidly growing population leading to rising expenditure on healthcare market in the Asia Pacific region makes it one of the most lucrative markets for biopharmaceutical bioseparation systems. Rise in income levels in emerging markets such as India and China has increased health care spending. Moreover, changing lifestyles and increase in urbanization in these countries have led to a gradual escalation in the incidence of lifestyle related diseases such as cancer, diabetes, and heart disease. This has opened up multiple avenues for expansion in the bio-pharmaceutical sector to conduct research and allocate substantial budget for the same.
Major players operating in the global biopharmaceutical bioseparation systems market include GE Healthcare Life Sciences, Merck Millipore, Danaher Corporation, 3M Company, Sartorius AG, Agilent Technologies, Waters Corporation, Asahi Kasei Corporation, and Bio-Rad Laboratories Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.